HISTOPATH (lesson 1)

HISTOPATH (lesson 1)
56問 • 2年前
  • Kmyching
  • 通報

    問題一覧

  • 1

    Due to arteriolar and capillary dilatation with increased rate of blood flow towards the site of injury

    rubor (redness)

  • 2

    Due to increased capillary permeability causing extravasation of blood fluid; recruitment of phagocytes

    tumor (swelling)

  • 3

    Due to transfer of internal heat to the surface or site of injury, brought about by increased blood content

    calor (heat)

  • 4

    diminished function: Destruction of the functioning units of the tissue

    functio laesa

  • 5

    Due to pressure upon the sensory nerve by the exudate/tumor

    dolor. (pain)

  • 6

    a rapid response to an injurious agent that aims to rapidly bring mediators of inflammation HALLMARK: increased neutrophils and macrophage

    acute inflammation

  • 7

    the escape of fluid, proteins and blood cells from the vascular system into interstitial tissue or body

    exudation

  • 8

    increase specific gravity, increased protein with infection

    exudate

  • 9

    low specific gravity

    transudate

  • 10

    Represents and intergrade between acute and chronic

    subchronic inflammation

  • 11

    Persistence of the injuring agent for weeks/years

    chronic inflammation

  • 12

    CHANGES IN CELLULAR GROWTH PATTERNS: organ/tissues smaller than normal.

    retrogressive changes

  • 13

    CHANGES IN CELLULAR GROWTH PATTERNS: organ/tissues larger than normal

    progressive changes

  • 14

    CHANGES IN CELLULAR GROWTH PATTERNS: tissue have abnormalities

    degenerative changes

  • 15

    incomplete/defective development of tissue/organ. Most commonly seen in one paired structures (kidneys, gonads, adrenals)

    aplasia

  • 16

    non-appearance of an organ.

    agenesia

  • 17

    failure of an organ to reach its full, mature size.

    hypoplasia

  • 18

    failure of an organ to form an opening

    atresia

  • 19

    refers to an acquired decrease in the size of a normally tissue or organ. Reduction in cell size.

    atrophy

  • 20

    occurs as a natural consequence of maturation, as in atrophy of the thymus and lymphoid tissue during puberty. Sexual organs and brain begin to atrophy at age 50.

    physiologic atrophy

  • 21

    refers to a decrease in size of organ, usually as a consequence of disease

    pathologic atrophy

  • 22

    refers to an increase in size of tissues or organs due to increase in size. NO NEW CELLS

    hypertrophy

  • 23

    usually seen in skeletal muscle, heart, kidneys, endocrine glands due to increased work load

    True hypertrophy

  • 24

    due to edema fluid and connective tissue proliferation

    false hypertrophy

  • 25

    involves one of paired organs when the opposite organ has been removed.

    compensatory hypertrophy

  • 26

    refers to an increase in size of an organ or tissue due to increase in the number of cells. CELL DIVISION

    hyperplasia

  • 27

    resulting from normal stimuli, hormonal such as hyperplasia of breast and uterus during pregnancy

    physiological hyperplasia

  • 28

    stimulation of growth factors, excess hormonal stimulation, viral infection, nodular

    pathologic hyperplasia

  • 29

    reversible change involving transformation in one type of adult cell to another

    metaplasia

  • 30

    is the regressive alteration in adult cells manifested by variation in size, shape, and orientation. Usually reversible and do not lead to tumor formation - CHANGES IN STRUCTURE

    dysplasia

  • 31

    usually used as criterion toward malignancy - irreversible, more primitive cells d

    anaplasia

  • 32

    continuous abnormal proliferation of the cells without control (no purpose or function)

    neoplasia

  • 33

    are those that do not produce death. Tumor is localized and doesn’t metastasize.

    benign tumor

  • 34

    will produce death eventually, however small they may be and wherever they may be located. Invasive and destroys adjacent areas.

    malignant tumor

  • 35

    Tumour implants continuous with the primary tumour. MOST RELIABLE FEATURE OF MALIGNANCY

    metastasis

  • 36

    neoplasm penetrates into a ‘’natural field’’. Most often in the peritoneal cavity.

    seeding within body cavities

  • 37

    most common pathway for CARCINOMAS (Epithelial)

    lymphatic spread

  • 38

    most common pathway for SARCOMAS (connective tissue)

    hematogenous spread

  • 39

    Grading of cancer attempts to establish some estimate of its AGGRESSIVENESS OR LEVEL OF MALIGNANCY based on the cytologic differentiation of tumor cells and the number of mitoses within the tumor.

    grading of tumors

  • 40

    is based on the size of the primary lesion, its extent of spread to regional lymph nodes and the presence or absence of metastases.

    staging

  • 41

    based upon the size of invasion

    t score

  • 42

    indicates the extent of lymph node involvement

    n score

  • 43

    indicates whether distant metastasis are present

    m score

  • 44

    Greek: “MONSTROUS TUMORS” Tumor with normal tissue or organ components that are inappropriate to surrounding tissues May contain hair, teeth, bones and very rare eyeballs, torso and hands.

    tetratomas

  • 45

    PROGRAM CELL DEATH”. vital process that helps eliminate unwanted cells. An internally programmed series of events effected by dedicated gene product.

    apoptosis

  • 46

    physiologic death of cells

    necrobiosis

  • 47

    pathologic death of cell which is due to disease or injury.

    necrosis

  • 48

    SULFIDE GAS FORMATION”

    gangrenous necrosis

  • 49

    involves the destruction of adipose tissue. Fat destruction due to release of pancreatic lipases. “CHALKY WHITE APPEARANCE”

    fat necrosis

  • 50

    Refers to the death or complete cessation of metabolic and functional activities of the organism or body. Cells survive 4-6 minutes after lungs and heart stop functioning.

    somatic death

  • 51

    this is the first demonstrable change observed, characterized by cooling of the body. 7°F PER HOUR

    algor mortis

  • 52

    refers to the rigidity or stiffening of the muscles, occurring 6-12hours after death.

    rigor mortis

  • 53

    refers to the purplish discoloration or lividity of the skin. Due to stasis and settling down of blood.

    livor mortis

  • 54

    this implies self-digestion of the cells, bacteria enhance the destruction of tissue.

    autolysis

  • 55

    refers to the drying and wrinkling of the cornea and the anterior chamber of the eyerefers to the drying and wrinkling of the cornea and the anterior chamber of the eye

    desiccation

  • 56

    characterized by foul-smelling gases, due to multiplying saprophytic organisms

    putrefaction

  • bacte (microbial control)

    bacte (microbial control)

    Kmyching · 26問 · 2年前

    bacte (microbial control)

    bacte (microbial control)

    26問 • 2年前
    Kmyching

    Collection

    Collection

    Kmyching · 6問 · 2年前

    Collection

    Collection

    6問 • 2年前
    Kmyching

    Histopath (somatic death)

    Histopath (somatic death)

    Kmyching · 25問 · 2年前

    Histopath (somatic death)

    Histopath (somatic death)

    25問 • 2年前
    Kmyching

    fresh tissue

    fresh tissue

    Kmyching · 54問 · 2年前

    fresh tissue

    fresh tissue

    54問 • 2年前
    Kmyching

    Staphylococcus

    Staphylococcus

    Kmyching · 7問 · 2年前

    Staphylococcus

    Staphylococcus

    7問 • 2年前
    Kmyching

    lesson 1 (cell injury, adaptation and inflammation and repair)

    lesson 1 (cell injury, adaptation and inflammation and repair)

    Kmyching · 67問 · 2年前

    lesson 1 (cell injury, adaptation and inflammation and repair)

    lesson 1 (cell injury, adaptation and inflammation and repair)

    67問 • 2年前
    Kmyching

    biopsy

    biopsy

    Kmyching · 14問 · 2年前

    biopsy

    biopsy

    14問 • 2年前
    Kmyching

    autopsy

    autopsy

    Kmyching · 20問 · 2年前

    autopsy

    autopsy

    20問 • 2年前
    Kmyching

    decalcification

    decalcification

    Kmyching · 20問 · 2年前

    decalcification

    decalcification

    20問 • 2年前
    Kmyching

    DEHYDRATION AND CLEARING

    DEHYDRATION AND CLEARING

    Kmyching · 27問 · 2年前

    DEHYDRATION AND CLEARING

    DEHYDRATION AND CLEARING

    27問 • 2年前
    Kmyching

    IMPREGNATION AND EMBEDDING

    IMPREGNATION AND EMBEDDING

    Kmyching · 21問 · 2年前

    IMPREGNATION AND EMBEDDING

    IMPREGNATION AND EMBEDDING

    21問 • 2年前
    Kmyching

    TRIMMING AND SECTIONING

    TRIMMING AND SECTIONING

    Kmyching · 35問 · 2年前

    TRIMMING AND SECTIONING

    TRIMMING AND SECTIONING

    35問 • 2年前
    Kmyching

    adhesive and staining

    adhesive and staining

    Kmyching · 43問 · 2年前

    adhesive and staining

    adhesive and staining

    43問 • 2年前
    Kmyching

    COMMON STAINING SOLUTION

    COMMON STAINING SOLUTION

    Kmyching · 19問 · 2年前

    COMMON STAINING SOLUTION

    COMMON STAINING SOLUTION

    19問 • 2年前
    Kmyching

    OTHER STAINING

    OTHER STAINING

    Kmyching · 26問 · 2年前

    OTHER STAINING

    OTHER STAINING

    26問 • 2年前
    Kmyching

    H&E STAINING, MOUNTING, RINGING AND LABELLING

    H&E STAINING, MOUNTING, RINGING AND LABELLING

    Kmyching · 19問 · 1年前

    H&E STAINING, MOUNTING, RINGING AND LABELLING

    H&E STAINING, MOUNTING, RINGING AND LABELLING

    19問 • 1年前
    Kmyching

    IMMUNOHISTOCHEMISTRY

    IMMUNOHISTOCHEMISTRY

    Kmyching · 11問 · 1年前

    IMMUNOHISTOCHEMISTRY

    IMMUNOHISTOCHEMISTRY

    11問 • 1年前
    Kmyching

    EPITHELIAL TUMOR MARKERS

    EPITHELIAL TUMOR MARKERS

    Kmyching · 5問 · 1年前

    EPITHELIAL TUMOR MARKERS

    EPITHELIAL TUMOR MARKERS

    5問 • 1年前
    Kmyching

    INTERMEDIATE FILAMENT MARKERS

    INTERMEDIATE FILAMENT MARKERS

    Kmyching · 6問 · 1年前

    INTERMEDIATE FILAMENT MARKERS

    INTERMEDIATE FILAMENT MARKERS

    6問 • 1年前
    Kmyching

    NEUROENDOCRINE MARKERS and GERM CELL TUMOR MARKERS

    NEUROENDOCRINE MARKERS and GERM CELL TUMOR MARKERS

    Kmyching · 6問 · 1年前

    NEUROENDOCRINE MARKERS and GERM CELL TUMOR MARKERS

    NEUROENDOCRINE MARKERS and GERM CELL TUMOR MARKERS

    6問 • 1年前
    Kmyching

    MESENCHYMAL TUMOR MARKERS

    MESENCHYMAL TUMOR MARKERS

    Kmyching · 5問 · 1年前

    MESENCHYMAL TUMOR MARKERS

    MESENCHYMAL TUMOR MARKERS

    5問 • 1年前
    Kmyching

    問題一覧

  • 1

    Due to arteriolar and capillary dilatation with increased rate of blood flow towards the site of injury

    rubor (redness)

  • 2

    Due to increased capillary permeability causing extravasation of blood fluid; recruitment of phagocytes

    tumor (swelling)

  • 3

    Due to transfer of internal heat to the surface or site of injury, brought about by increased blood content

    calor (heat)

  • 4

    diminished function: Destruction of the functioning units of the tissue

    functio laesa

  • 5

    Due to pressure upon the sensory nerve by the exudate/tumor

    dolor. (pain)

  • 6

    a rapid response to an injurious agent that aims to rapidly bring mediators of inflammation HALLMARK: increased neutrophils and macrophage

    acute inflammation

  • 7

    the escape of fluid, proteins and blood cells from the vascular system into interstitial tissue or body

    exudation

  • 8

    increase specific gravity, increased protein with infection

    exudate

  • 9

    low specific gravity

    transudate

  • 10

    Represents and intergrade between acute and chronic

    subchronic inflammation

  • 11

    Persistence of the injuring agent for weeks/years

    chronic inflammation

  • 12

    CHANGES IN CELLULAR GROWTH PATTERNS: organ/tissues smaller than normal.

    retrogressive changes

  • 13

    CHANGES IN CELLULAR GROWTH PATTERNS: organ/tissues larger than normal

    progressive changes

  • 14

    CHANGES IN CELLULAR GROWTH PATTERNS: tissue have abnormalities

    degenerative changes

  • 15

    incomplete/defective development of tissue/organ. Most commonly seen in one paired structures (kidneys, gonads, adrenals)

    aplasia

  • 16

    non-appearance of an organ.

    agenesia

  • 17

    failure of an organ to reach its full, mature size.

    hypoplasia

  • 18

    failure of an organ to form an opening

    atresia

  • 19

    refers to an acquired decrease in the size of a normally tissue or organ. Reduction in cell size.

    atrophy

  • 20

    occurs as a natural consequence of maturation, as in atrophy of the thymus and lymphoid tissue during puberty. Sexual organs and brain begin to atrophy at age 50.

    physiologic atrophy

  • 21

    refers to a decrease in size of organ, usually as a consequence of disease

    pathologic atrophy

  • 22

    refers to an increase in size of tissues or organs due to increase in size. NO NEW CELLS

    hypertrophy

  • 23

    usually seen in skeletal muscle, heart, kidneys, endocrine glands due to increased work load

    True hypertrophy

  • 24

    due to edema fluid and connective tissue proliferation

    false hypertrophy

  • 25

    involves one of paired organs when the opposite organ has been removed.

    compensatory hypertrophy

  • 26

    refers to an increase in size of an organ or tissue due to increase in the number of cells. CELL DIVISION

    hyperplasia

  • 27

    resulting from normal stimuli, hormonal such as hyperplasia of breast and uterus during pregnancy

    physiological hyperplasia

  • 28

    stimulation of growth factors, excess hormonal stimulation, viral infection, nodular

    pathologic hyperplasia

  • 29

    reversible change involving transformation in one type of adult cell to another

    metaplasia

  • 30

    is the regressive alteration in adult cells manifested by variation in size, shape, and orientation. Usually reversible and do not lead to tumor formation - CHANGES IN STRUCTURE

    dysplasia

  • 31

    usually used as criterion toward malignancy - irreversible, more primitive cells d

    anaplasia

  • 32

    continuous abnormal proliferation of the cells without control (no purpose or function)

    neoplasia

  • 33

    are those that do not produce death. Tumor is localized and doesn’t metastasize.

    benign tumor

  • 34

    will produce death eventually, however small they may be and wherever they may be located. Invasive and destroys adjacent areas.

    malignant tumor

  • 35

    Tumour implants continuous with the primary tumour. MOST RELIABLE FEATURE OF MALIGNANCY

    metastasis

  • 36

    neoplasm penetrates into a ‘’natural field’’. Most often in the peritoneal cavity.

    seeding within body cavities

  • 37

    most common pathway for CARCINOMAS (Epithelial)

    lymphatic spread

  • 38

    most common pathway for SARCOMAS (connective tissue)

    hematogenous spread

  • 39

    Grading of cancer attempts to establish some estimate of its AGGRESSIVENESS OR LEVEL OF MALIGNANCY based on the cytologic differentiation of tumor cells and the number of mitoses within the tumor.

    grading of tumors

  • 40

    is based on the size of the primary lesion, its extent of spread to regional lymph nodes and the presence or absence of metastases.

    staging

  • 41

    based upon the size of invasion

    t score

  • 42

    indicates the extent of lymph node involvement

    n score

  • 43

    indicates whether distant metastasis are present

    m score

  • 44

    Greek: “MONSTROUS TUMORS” Tumor with normal tissue or organ components that are inappropriate to surrounding tissues May contain hair, teeth, bones and very rare eyeballs, torso and hands.

    tetratomas

  • 45

    PROGRAM CELL DEATH”. vital process that helps eliminate unwanted cells. An internally programmed series of events effected by dedicated gene product.

    apoptosis

  • 46

    physiologic death of cells

    necrobiosis

  • 47

    pathologic death of cell which is due to disease or injury.

    necrosis

  • 48

    SULFIDE GAS FORMATION”

    gangrenous necrosis

  • 49

    involves the destruction of adipose tissue. Fat destruction due to release of pancreatic lipases. “CHALKY WHITE APPEARANCE”

    fat necrosis

  • 50

    Refers to the death or complete cessation of metabolic and functional activities of the organism or body. Cells survive 4-6 minutes after lungs and heart stop functioning.

    somatic death

  • 51

    this is the first demonstrable change observed, characterized by cooling of the body. 7°F PER HOUR

    algor mortis

  • 52

    refers to the rigidity or stiffening of the muscles, occurring 6-12hours after death.

    rigor mortis

  • 53

    refers to the purplish discoloration or lividity of the skin. Due to stasis and settling down of blood.

    livor mortis

  • 54

    this implies self-digestion of the cells, bacteria enhance the destruction of tissue.

    autolysis

  • 55

    refers to the drying and wrinkling of the cornea and the anterior chamber of the eyerefers to the drying and wrinkling of the cornea and the anterior chamber of the eye

    desiccation

  • 56

    characterized by foul-smelling gases, due to multiplying saprophytic organisms

    putrefaction